Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UCLA School Of Nursing Deploys QuantRx PadKit For Cervical Cancer Study
The study is funded by an initial grant from the UCLA School of Nursing and intended to identify a low cost diagnostic solution for cervical cancer screening in
The study is funded by an initial grant from the UCLA School of Nursing and intended to identify a low cost diagnostic solution for cervical cancer screening in
Delcath has also reported that sufficient patient events had occurred in its randomized, multi-center Phase III trial of melphalan for data analysis to begin. Under the Expanded Access
The acquisition is expected to strengthen AB Sciex’s position in liquid chromatography, which is used in a broad range of life science applications such as protein biomarker research,
The acquisition provides AB Sciex with an entry into the liquid chromatography market through the ability to provide instrumentation and consumables used to separate, identify and quantify small
Jiangxi Leading Group Office issued an ordinance to add Jiangxi RongYu product, the Tongmai lipid-lowering chew film, to the National Essential Drug List. By the decree of the
The company said that Indomethacin for injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750g when after 48
The company said that the inspection covered all areas of the organisation and systems involved in the production of sterile penicillin products. After the seven-day audit, the site
Under the terms of agreement, EndoChoice’s gastroenterology-focused sales force will introduce Exagen’s gene expression tests for the diagnosis of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
The company has incurred an operating loss of $15.1m for the three months ended December 31, 2009 as compared to $17.1m for the same period in 2008. The
Excluding one-time items, adjusted earnings were 79 cents per share. Revenue totaled $10.09bn in the quarter, an increase of 67%, compared to $6.03bn during the same period last